Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes Mellitus

Update Il y a 4 ans
Reference: NCT00225277

Woman and Man

Extract

The purpose of this study was to determine the efficacy of pioglitazone, once daily (QD), compared to glimepiride on atherosclerotic disease measured by intravascular ultrasound.


Inclusion criteria

  • Diabetes Mellitus


Links